Compare VNCE & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VNCE | CLNN |
|---|---|---|
| Founded | 2002 | 2012 |
| Country | United States | United States |
| Employees | N/A | 79 |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.1M | 85.7M |
| IPO Year | 2013 | N/A |
| Metric | VNCE | CLNN |
|---|---|---|
| Price | $6.28 | $6.01 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | $5.17 | ★ $33.75 |
| AVG Volume (30 Days) | ★ 358.7K | 80.0K |
| Earning Date | 04-15-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 132.45 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $300,007,000.00 | N/A |
| Revenue This Year | $5.86 | $17.64 |
| Revenue Next Year | N/A | $19,516.77 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 2.23 | N/A |
| 52 Week Low | $1.19 | $3.25 |
| 52 Week High | $8.20 | $13.50 |
| Indicator | VNCE | CLNN |
|---|---|---|
| Relative Strength Index (RSI) | 53.33 | 50.83 |
| Support Level | $2.41 | $5.43 |
| Resistance Level | N/A | $6.63 |
| Average True Range (ATR) | 0.95 | 0.39 |
| MACD | -0.08 | 0.06 |
| Stochastic Oscillator | 44.38 | 59.38 |
Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale and Vince Direct-to-consumer. It operates its e-commerce business through its website. Maximum of its revenue generated from Vince Wholesale segment.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.